About
Octant Bio develops orally administered small molecule therapeutics designed to correct protein misfolding and mistrafficking, focusing on diseases such as Retinitis Pigmentosa caused by genetic mutations.
Explore Octant Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.